...BRCA2, we assessed the multifactorial posterior probability of VUS in BRCA1 and BRCA2 and compared these analyses with i...
...BRCA2 defects in a significant proportion (14%) of SS tumors. Aberrations in PRKCQ were found to occur in 20% of tumors ...
...BRCA2, TP53 and PTEN gene mutations and recruited from March 2007 to June 2015 in the Hong Kong Hereditary and High Risk...
...BRCA2 mutation carriers are at substantially increased risk for developing breast and/or ovarian cancer, and are offered...
...BRCA2, BRCA1 or RPA, resulted in a distinct mutational signature associated with significant increases in break-induced ...
...BRCA2 genes explain a large part of hereditary breast cancer. Several studies have shown that BRCA1 and BRCA2 tumors exh...
...BRCA2-containing complex subunit 3 (BRCC3); and guanylate cyclase 1, soluble, alpha 3 (GUCY1A3) as well as a clinical ph...
...BRCA2 gene have a specifically increased lifetime risk of developing breast and tubo-ovarian cancer. Moreover, they are ...
...BRCA2. This monographic issue provides an update on our knowledge of this syndrome with particular emphasis on the risk ...
...BRCA2 mutation carriers without a personal history of breast cancer. Premature menopause affects significantly also bone...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
